Evidence map›Paper›PMID 27221736›Full record

ArticleOphthalmology2016

The Philadelphia Glaucoma Detection and Treatment Project: Detection Rates and Initial Management.

Michael Waisbourd, Noelle L Pruzan, Deiana Johnson, Angela Ugorets, John E Crews, Jinan B Saaddine, Jeffery D Henderer, Lisa A Hark, L Jay Katz

Abstract readMulticenter Study
In one paragraph

Article in Ophthalmology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Practice Guidelines for Ocular Telehealth-Diabetic Retinopathy, Third Edition.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2020
    Article
  13. Telemedicine for Glaucoma: Guidelines and Recommendations.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2020
    Article
  14. Article
  15. Dose-Response of Intracameral Bimatoprost Sustained-Release Implant and Topical Bimatoprost in Lowering Intraocular Pressure.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2019
    Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Michael WaisbourdWills Eye Hospital Glaucoma Research Center, Philadelphia, Pennsylvania. Electronic address: MWaisbourd@willseye.org.
Noelle L PruzanWills Eye Hospital Glaucoma Research Center, Philadelphia, Pennsylvania.
Deiana JohnsonWills Eye Hospital Glaucoma Research Center, Philadelphia, Pennsylvania.
Angela UgoretsWills Eye Hospital Glaucoma Research Center, Philadelphia, Pennsylvania.
John E CrewsVision Health Initiative, Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Jinan B SaaddineVision Health Initiative, Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Jeffery D HendererLewis Katz School of Medicine at Temple University, Department of Ophthalmology, Philadelphia, Pennsylvania.
Lisa A HarkWills Eye Hospital Glaucoma Research Center, Philadelphia, Pennsylvania.
L Jay KatzWills Eye Hospital Glaucoma Research Center, Philadelphia, Pennsylvania.
Wills Eye Hospital · USCenters for Disease Control and Prevention · USTemple University · US

Funding

IMPROVING ACCESS TO EYE CARE AMONG PERSONS AT HIGH RISK FOR GLAUCOMA IN PHILADELPU58DP004060 · DP · WILLS EYE HEALTH SYSTEM · PI KATZ, L. JAY · 2012 to 2013
$1.9M
Intramural CDC HHS CC999999NCCDPHP CDC HHS U58 DP004060
6 · The paper itself

Abstract

purposeTo evaluate the detection rates of glaucoma-related diagnoses and the initial treatments received in the Philadelphia Glaucoma Detection and Treatment Project, a community-based initiative aimed at improving the detection, treatment, and follow-up care of individuals at risk for glaucoma.

designRetrospective analysis.

participantsA total of 1649 individuals at risk for glaucoma who were examined and treated in 43 community centers located in underserved communities of Philadelphia.

methodsIndividuals were enrolled if they were African American aged ≥50 years, were any other adult aged ≥60 years, or had a family history of glaucoma. After attending an informational glaucoma workshop, participants underwent a targeted glaucoma examination including an ocular, medical, and family history; visual acuity testing, intraocular pressure (IOP) measurement, and corneal pachymetry; slit-lamp and optic nerve examination; automated visual field testing; and fundus color photography. If indicated, treatments included selective laser trabeculoplasty (SLT), laser peripheral iridotomy (LPI), or IOP-lowering medications. Follow-up examinations were scheduled at the community sites after 4 to 6 weeks or 4 to 6 months, depending on the clinical scenario.

main outcome measuresDetection rates of glaucoma-related diagnoses and types of treatments administered.

resultsOf the 1649 individuals enrolled, 645 (39.1%) received a glaucoma-related diagnosis; 20.0% (n = 330) were identified as open-angle glaucoma (OAG) suspects, 9.2% (n = 151) were identified as having narrow angles (or as a primary angle closure/suspect), and 10.0% (n = 164) were diagnosed with glaucoma, including 9.0% (n = 148) with OAG and 1.0% (n = 16) with angle-closure glaucoma. Overall, 39.0% (n = 64 of 164) of those diagnosed with glaucoma were unaware of their diagnosis. A total of 196 patients (11.9%) received glaucoma-related treatment, including 84 (5.1%) who underwent LPI, 13 (0.8%) who underwent SLT, and 103 (6.2%) who were prescribed IOP-lowering medication.

conclusionsTargeting individuals at risk for glaucoma in underserved communities in Philadelphia yielded a high detection rate (39.1%) of glaucoma-related diagnoses. Providing examinations and offering treatment, including first-line laser procedures, at community-based sites providing services to older adults are effective to improve access to eye care by underserved populations.

Indexed as

IridectomyTrabeculectomyAgedAged, 80 and overAntihypertensive AgentsBlack or African AmericanCorneal PachymetryFemaleGlaucoma, Angle-ClosureGlaucoma, Open-AngleGonioscopyHumansIntraocular PressureMaleMiddle AgedOcular HypertensionAntihypertensive Agents

Identifiers

PMID27221736
PMCPMC4958560
OpenAlexW2401501439

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.